These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16210133)

  • 1. Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
    Zhou H; Latham CW; Zander DS; Margolin SB; Visner GA
    J Heart Lung Transplant; 2005 Oct; 24(10):1577-85. PubMed ID: 16210133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of airway epithelial injury in murine orthotopic tracheal allograft rejection.
    Kuo E; Bharat A; Shih J; Street T; Norris J; Liu W; Parks W; Walter M; Patterson GA; Mohanakumar T
    Ann Thorac Surg; 2006 Oct; 82(4):1226-33. PubMed ID: 16996912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirfenidone inhibits obliterative airway disease in a murine heterotopic tracheal transplant model.
    McKane BW; Fernandez F; Narayanan K; Marshbank S; Margolin SB; Jendrisak M; Mohanakumar T
    Transplantation; 2004 Mar; 77(5):664-9. PubMed ID: 15021826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow.
    Fernández FG; McKane B; Marshbank S; Patterson GA; Mohanakumar T
    J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S232-8. PubMed ID: 15993779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
    Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
    Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus treatment effectively inhibits progression of obliterative airway disease even at later stages of disease development.
    Hollmén M; Tikkanen JM; Nykänen AI; Koskinen PK; Lemström KB
    J Heart Lung Transplant; 2008 Aug; 27(8):856-64. PubMed ID: 18656798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly (ADP) ribose synthetase inhibition reduces obliterative airway disease in rat tracheal allografts.
    Farivar AS; Woolley SM; Naidu BV; Fraga CH; Byrne K; Thomas R; Salzman AL; Szabo CS; Mulligan MS
    J Heart Lung Transplant; 2004 Aug; 23(8):993-1002. PubMed ID: 15312830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FR167653 reduces obliterative airway disease in rats.
    Farivar AS; Mackinnon-Patterson B; Woolley S; Namkung J; Shimamoto A; Verrier ED; Mulligan MS
    J Heart Lung Transplant; 2004 Aug; 23(8):985-92. PubMed ID: 15312829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presensitization accelerates chronic allograft rejection in a heterotopic rat tracheal allograft model with immunosuppression.
    Okumoto T; Yamane M; Sano Y; Aoe M; Date H; Shimizu N
    Transpl Immunol; 2007 Jun; 17(4):249-54. PubMed ID: 17493527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible costimulator blockade prolongs airway luminal patency in a mouse model of obliterative bronchiolitis.
    KleinJan A; Willart MA; Kuipers H; Coyle AJ; Hoogsteden HC; Lambrecht BN
    Transplantation; 2008 Nov; 86(10):1436-44. PubMed ID: 19034015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor antigen-presenting cells are important in the development of obliterative airway disease.
    Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
    J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cyclosporine A and interleukin-2 in obliterative airway disease in a rat tracheal transplant model.
    Gu Y; Takao M; Kai M; Lu L; Shimamoto A; Onoda K; Shimono T; Tanaka K; Shimpo H; Shiraishi T; Yada I
    Ann Thorac Cardiovasc Surg; 2000 Aug; 6(4):224-31. PubMed ID: 11042477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factor upregulation during obliterative bronchiolitis in the mouse model.
    Aris RM; Walsh S; Chalermskulrat W; Hathwar V; Neuringer IP
    Am J Respir Crit Care Med; 2002 Aug; 166(3):417-22. PubMed ID: 12153981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pirfenidone inhibits inflammatory responses and ameliorates allograft injury in a rat lung transplant model.
    Liu H; Drew P; Cheng Y; Visner GA
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):852-8. PubMed ID: 16153939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
    Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC
    J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory viral infection in obliterative airway disease after orthotopic tracheal transplantation.
    Kuo E; Bharat A; Goers T; Chapman W; Yan L; Street T; Lu W; Walter M; Patterson A; Mohanakumar T
    Ann Thorac Surg; 2006 Sep; 82(3):1043-50. PubMed ID: 16928532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pirfenidone: A novel anti-fibrotic agent and progressive chronic allograft rejection.
    Dosanjh A; Ikonen T; Wan B; Morris RE
    Pulm Pharmacol Ther; 2002; 15(5):433-7. PubMed ID: 12406665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor plays a major role in development of experimental obliterative bronchiolitis.
    Krebs R; Hollmén ME; Tikkanen JM; Wu Y; Hicklin DJ; Koskinen PK; Lemström KB
    Transplant Proc; 2006 Dec; 38(10):3266-7. PubMed ID: 17175244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.